Evofem Biosciences' market value is the price at which a share of Evofem Biosciences trades on a public exchange. It measures the collective expectations of Evofem Biosciences investors about its performance. Evofem Biosciences is selling at 0.0092 as of the 22nd of January 2026; that is 2.22 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0086. With this module, you can estimate the performance of a buy and hold strategy of Evofem Biosciences and determine expected loss or profit from investing in Evofem Biosciences over a given investment horizon. Check out Evofem Biosciences Correlation, Evofem Biosciences Volatility and Evofem Biosciences Alpha and Beta module to complement your research on Evofem Biosciences.
Please note, there is a significant difference between Evofem Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evofem Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evofem Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evofem Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evofem Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evofem Biosciences.
0.00
10/24/2025
No Change 0.00
0.0
In 3 months and 1 day
01/22/2026
0.00
If you would invest 0.00 in Evofem Biosciences on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding Evofem Biosciences or generate 0.0% return on investment in Evofem Biosciences over 90 days. Evofem Biosciences is related to or competes with Chia Tai, Biora Therapeutics, and International Stem. Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet nee... More
Evofem Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evofem Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evofem Biosciences upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evofem Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evofem Biosciences' standard deviation. In reality, there are many statistical measures that can use Evofem Biosciences historical prices to predict the future Evofem Biosciences' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evofem Biosciences. Your research has to be compared to or analyzed against Evofem Biosciences' peers to derive any actionable benefits. When done correctly, Evofem Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evofem Biosciences.
Evofem Biosciences January 22, 2026 Technical Indicators
Evofem Biosciences appears to be out of control, given 3 months investment horizon. Evofem Biosciences secures Sharpe Ratio (or Efficiency) of 0.0506, which denotes the company had a 0.0506 % return per unit of risk over the last 3 months. By reviewing Evofem Biosciences' technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please utilize Evofem Biosciences' Mean Deviation of 6.4, coefficient of variation of 1976.98, and Downside Deviation of 12.36 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Evofem Biosciences holds a performance score of 4. The firm shows a Beta (market volatility) of 2.11, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Evofem Biosciences will likely underperform. Please check Evofem Biosciences' treynor ratio and the relationship between the semi variance and period momentum indicator , to make a quick decision on whether Evofem Biosciences' price patterns will revert.
Auto-correlation
0.17
Very weak predictability
Evofem Biosciences has very weak predictability. Overlapping area represents the amount of predictability between Evofem Biosciences time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evofem Biosciences price movement. The serial correlation of 0.17 indicates that over 17.0% of current Evofem Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient
0.17
Spearman Rank Test
-0.38
Residual Average
0.0
Price Variance
0.0
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Other Information on Investing in Evofem Pink Sheet
Evofem Biosciences financial ratios help investors to determine whether Evofem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evofem with respect to the benefits of owning Evofem Biosciences security.